```

[Federal Register Volume 89, Number 235 (Friday, December 6, 2024)]
[Notices]
[Page 97071]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-28728]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1462]

Importer of Controlled Substances Application: Noramco

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Noramco has applied to be registered as an importer of basic 
class(es) of controlled substance(s). Refer to Supplementary 
Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants, therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
January 6, 2025. Such persons may also file a written request for a 
hearing on the application on or before January 6, 2025.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment. All 
requests for a hearing must be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152. All requests for a hearing should also be 
sent to: Drug Enforcement Administration, Attn: Administrator, 8701 
Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on October 9, 2024, Noramco, 500 Swedes Landing Road, 
Wilmington, Delaware 19801-4417, applied to be registered as an 
importer of the following basic class(es) of controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid...............    2010  I
Marihuana...............................    7360  I
Tetrahydrocannabinols...................    7370  I
Methadone-Intermediate..................    9254  II
Opium, Raw..............................    9600  II
Opium Extracts..........................    9610  II
Opium Fluid Extract.....................    9620  II
Opium Tincture..........................    9630  II
Opium, Powdered.........................    9639  II
Opium, Granulated.......................    9640  II
Opium Poppy/Poppy Straw.................    9650  II
Noroxymorphone..........................    9668  II
Poppy Straw Concentrate.................    9670  II
Tapentadol..............................    9780  II
------------------------------------------------------------------------

    The company plans to import Poppy Straw Concentrate (9670) to bulk 
manufacture other controlled substances for distribution to its 
customers. The company plans to import an intermediate form of 
Tapentadol (9780) to bulk manufacture Tapentadol for distribution to 
its customers. In reference to drug codes 7360 (Marihuana) and 7370 
(Tetrahydrocannabinols), the company plans to import a synthetic 
cannabidiol and a synthetic Tetrahydrocannabinol. No other activities 
for these drug codes are authorized for this registration.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug Administration approved or non-approved finished 
dosage forms for commercial sale.

Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2024-28728 Filed 12-5-24; 8:45 am]
BILLING CODE P
```